Scinai Immunotherapeutics (SCNI) EPS (Basic) Growth (1y) (2015 - 2026)
Scinai Immunotherapeutics (SCNI) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | -16.29% |
| 10 | Scinai Immunotherapeutics | 12.68 Mn | -3.10 Bn | -1.12 Mn | 19.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.82% |
| Jun 30, 2025 | 86.59% |
| Mar 31, 2025 | -123.06% |
| Dec 31, 2024 | 96.87% |
| Sep 30, 2024 | 13,427,618.47% |
| Jun 30, 2024 | -119.05% |
| Mar 31, 2024 | -95.36% |
| Dec 31, 2023 | 87.94% |
| Sep 30, 2023 | 92.04% |
| Jun 30, 2023 | -85.41% |
| Mar 31, 2023 | 175.34% |
| Dec 31, 2022 | -485.02% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 109.12% |
| Mar 31, 2022 | 89.22% |
| Dec 31, 2021 | 102.25% |
| Sep 30, 2021 | -109.12% |
| Mar 31, 2021 | 95.20% |
| Sep 30, 2020 | 313.92% |
| Mar 31, 2020 | -147.62% |